CARBAPENEM & MONOBACTUM
CARBAPENEM & MONOBACTUM
- Are beta-lactam antibiotics.
- Beta-lactam antibiotics – Drugs containing ß–lactam ring in their structure.
- Drugs:
- Penicillins
- Cephalosporins (above both discussed separately)
- Monobactams e.g. aztreonam
- Carbapenems e.g. imipenem
General features:
- All ß-lactam antibiotics are bactericidal drugs.
- MOA:
- Bind to specific receptors (penicillin-binding proteins; PBPs) on bacterial cell membrane.
- Inhibits transpeptidase enzyme
- Responsible for peptidoglycan chain cross-linking.
- Bacteria formed in drug presence are without cell wall –> Dies due to water imbibition. (cell wall provides turgidity).
I) Monobactams:
- Only beta-lactam antibiotic for patients with severe penicillin or cephalosporins allergy
- Since not cross allergenic.
- Drugs: Aztreonam.
- Active against β-lactamase producing gram negative rods including Pseudomonas.
- No activity against gram-positive organisms or anaerobes.
- Administered i.v.
- Prolonged half-life in renal failure.
II) Carbapenems:
- Are β-lactamase resistant.
- DOC for Enterobacter, Klebsiella & acinetobacter species.
- Wide spectrum of activity – Including gram-positive cocci, gram-negative rods & anaerobes.
- Only β-lactams, reliably efficacious against ESBL (extended spectrum β-lactamase) producing organisms.
Drugs: Imipenem, doripenem, meropenem & ertapenem.
Uses:
- For Pseudomonas treatment:
- Meropenem – Most active & Ertapenem – least.
- Should be combined with aminoglycosides.
Individual drug description:
- Imipenem:
- Rapidly inactivated by renal dehydropeptidase I enzyme.
- Always combined with cilastatin.
- Increases imipenem half-life.
- Inhibits nephrotoxic metabolite formation.
- (Note on cilastatin: Inhibitor of renal dehydropeptidase I enzyme).
- Adverse effects:
- Imipenem-cilastatin combination include seizures & gastrointestinal distress (Main).
- Meropenem, doripenem & ertapenem:
- Not metabolized by renal dehydropeptidase.
- Hence, less likely seizures.
- Ertapenem:
- Very long acting.
- Inactive against Pseudomonas.
- Loracarbef:
- Chemically similar to cefaclor.
- Oral drug.
- Overdose can cause seizures.
Exam Important
- Carbapenem & Monobactum are beta-lactum antibiotics.
- Aztreonam is a Monobactam.
- Imipenem is a Carbapenem.
- All ß-lactam antibiotics are bactericidal drugs.
- Monobactam is only beta-lactam antibiotic for patients with severe penicillin or cephalosporins allergy, since not cross allergenic.
- Aztreonam is active against β-lactamase producing gram-negative rods, including Pseudomonas.
- Carbapenem is β-lactamase resistant which is DOC for Enterobacter, Klebsiella & acinetobacter species.
- Carbapenem is only β-lactams, reliably efficacious against ESBL (extended spectrum β-lactamase) producing organisms.
- Imipenem, doripenem, meropenem & ertapenem are all carbapenem.
- Meropenem is a most active & Ertapenem is least active carbapenem.
- Imipenem is always combined with cilastatin because it gets rapidly inactivated by renal dehydropeptidase I enzyme.
- Cilastatin is an inhibitor of renal dehydropeptidase I enzyme.
- Imipenem-cilastatin combination mainly causes seizures & gastrointestinal distress (adverse effects).
- Meropenem, doripenem & ertapenem are not metabolized by renal dehydropeptidase, hence, less likely seizures.
- Ertapenem is very long-acting & are inactive against Pseudomonas.
Don’t Forget to Solve all the previous Year Question asked on CARBAPENEM & MONOBACTUM



